Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Decreased by Kolinsky Wealth Management LLC

Kolinsky Wealth Management LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 873 shares of the medical equipment provider’s stock after selling 147 shares during the quarter. Kolinsky Wealth Management LLC’s holdings in Intuitive Surgical were worth $429,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. FMR LLC increased its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Fisher Asset Management LLC grew its position in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Baillie Gifford & Co. increased its stake in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after buying an additional 24,183 shares during the period. American Century Companies Inc. raised its position in shares of Intuitive Surgical by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after buying an additional 70,556 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Intuitive Surgical by 1.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock worth $1,094,288,000 after acquiring an additional 28,703 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. The trade was a 15.83 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock worth $26,080,251 in the last 90 days. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ISRG. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Leerink Partners lifted their price target on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Stifel Nicolaus upped their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. Truist Financial boosted their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $526.06.

Intuitive Surgical Stock Up 0.6 %

Shares of NASDAQ:ISRG opened at $542.00 on Friday. The company’s fifty day moving average is $510.03 and its two-hundred day moving average is $468.41. The company has a market cap of $193.05 billion, a P/E ratio of 87.14, a price-to-earnings-growth ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.